Targeting Histone Modifications in Bone and Lung Metastatic Cancers
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Histone Modifications in Bone and Lung Metastatic Cancers
Authors
Keywords
-
Journal
Current Osteoporosis Reports
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-03-15
DOI
10.1007/s11914-021-00670-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A short guide to histone deacetylases including recent progress on class II enzymes
- (2020) Suk-Youl Park et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Integrative Analysis of Sirtuins and Their Prognostic Significance in Clear Cell Renal Cell Carcinoma
- (2020) Ying Tan et al. Frontiers in Oncology
- Estrogen receptor β exerts tumor suppressive effects in prostate cancer through repression of androgen receptor activity
- (2020) Surendra Chaurasiya et al. PLoS One
- Wnt Signaling Drives Prostate Cancer Bone Metastatic Tropism and Invasion
- (2020) Yugang Wang et al. Translational Oncology
- Novel HDAC11 inhibitors suppress lung adenocarcinoma stem cell self-renewal and overcome drug resistance by suppressing Sox2
- (2020) Namrata Bora-Singhal et al. Scientific Reports
- Editorial: The Role of Breast Cancer Stem Cells in Clinical Outcomes
- (2020) Dayanidhi Raman et al. Frontiers in Oncology
- Histone deacetylase inhibition prevents the growth of primary and metastatic osteosarcoma
- (2020) Jeremy J. McGuire et al. INTERNATIONAL JOURNAL OF CANCER
- Immune checkpoint inhibitor toxicities: systems-based approaches to improve patient care and research
- (2020) Douglas B Johnson et al. LANCET ONCOLOGY
- Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Michael Gnant et al. LANCET ONCOLOGY
- Loss of Sirtuin 1 Alters the Secretome of Breast Cancer Cells by Impairing Lysosomal Integrity
- (2019) Arash Latifkar et al. DEVELOPMENTAL CELL
- The mTOR Inhibitor Everolimus Overcomes CXCR4-Mediated Resistance to Histone Deacetylase Inhibitor Panobinostat through Inhibition of p21 and Mitotic Regulators
- (2019) Katia Beider et al. BIOCHEMICAL PHARMACOLOGY
- BRD4 inhibitor and histone deacetylase inhibitor synergistically inhibit the proliferation of gallbladder cancer in vitro and in vivo
- (2019) Shilei Liu et al. CANCER SCIENCE
- Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells
- (2019) Tessa Knox et al. Scientific Reports
- Acute and chronic hypoxia differentially predispose lungs for metastases
- (2019) Moritz Reiterer et al. Scientific Reports
- Epigenetically Down-Regulated Acetyltransferase PCAF Increases the Resistance of Colorectal Cancer to 5-Fluorouracil
- (2019) Tong Liu et al. NEOPLASIA
- DNA Methylation Readers and Cancer: Mechanistic and Therapeutic Applications
- (2019) Niaz Mahmood et al. Frontiers in Oncology
- HDAC7 regulates histone 3 lysine 27 acetylation and transcriptional activity at super-enhancer-associated genes in breast cancer stem cells
- (2019) Corrado Caslini et al. ONCOGENE
- Histone deacetylase 11 inhibition promotes breast cancer metastasis from lymph nodes
- (2019) Patrick L. Leslie et al. Nature Communications
- Overexpressed HDAC8 in cervical cancer cells shows functional redundancy of tubulin deacetylation with HDAC6
- (2018) G. R. Vanaja et al. Cell Communication and Signaling
- PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/BRCA1 DNA damage repair complex in prostate cancer cells
- (2018) Linglong Yin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis
- (2018) Willemijne A M E Schrijver et al. JNCI-Journal of the National Cancer Institute
- Wnt signaling in bone metastasis: mechanisms and therapeutic opportunities
- (2018) Xin Li et al. LIFE SCIENCES
- Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis
- (2018) Anxo Martinez-Ordoñez et al. ONCOGENE
- Pharmacological activation of estrogen receptor beta augments innate immunity to suppress cancer metastasis
- (2018) Linjie Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis
- (2018) Willemijne A M E Schrijver et al. JNCI-Journal of the National Cancer Institute
- Targeting estrogen receptor beta (ERβ) for treatment of ovarian cancer: importance of KDM6B and SIRT1 for ERβ expression and functionality
- (2018) Giulia Pinton et al. Oncogenesis
- Overall survival in female Medicare beneficiaries with early stage breast cancer receiving bisphosphonates or denosumab.
- (2018) Raul A Herrera Pena et al. JOURNAL OF CLINICAL ONCOLOGY
- Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model
- (2018) Diana Llopiz et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CBP/β-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer
- (2018) Alexander Ring et al. Cancers
- The role of histone deacetylase inhibitors in metastatic breast cancer
- (2018) Bruna Zucchetti et al. BREAST
- Histone Deacetylase Inhibitors as Anticancer Drugs
- (2017) Tomas Eckschlager et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Differential effects on lung and bone metastasis of breast cancer by Wnt signalling inhibitor DKK1
- (2017) Xueqian Zhuang et al. NATURE CELL BIOLOGY
- Differential expression of the sirtuin family in renal cell carcinoma: Aspects of carcinogenesis and prognostic significance
- (2017) Seong Uk Jeh et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Clinical characteristics and prognoses of patients treated surgically for metastatic lung tumors
- (2017) Xiaoliang Zhao et al. Oncotarget
- HAT1 induces lung cancer cell apoptosis via up regulating Fas
- (2017) Na Han et al. Oncotarget
- Clinical characteristics and risk factors for developing bone metastases in patients with breast cancer
- (2017) Wen-Zhao Chen et al. Scientific Reports
- HDAC2 promotes the migration and invasion of non-small cell lung cancer cells via upregulation of fibronectin
- (2016) Li Li et al. BIOMEDICINE & PHARMACOTHERAPY
- HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma
- (2016) Swathi Ramakrishnan et al. BMC CANCER
- Oral Bisphosphonates and Improved Survival of Breast Cancer
- (2016) Gad Rennert et al. CLINICAL CANCER RESEARCH
- HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma
- (2016) Hong Zheng et al. CLINICAL CANCER RESEARCH
- Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study
- (2016) Roisin M. Connolly et al. CLINICAL CANCER RESEARCH
- Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow
- (2016) Rachelle W. Johnson et al. NATURE CELL BIOLOGY
- Identification of MYST3 as a novel epigenetic activator of ERα frequently amplified in breast cancer
- (2016) L Yu et al. ONCOGENE
- Dormant breast cancer micrometastases reside in specific bone marrow niches that regulate their transit to and from bone
- (2016) Trevor T. Price et al. Science Translational Medicine
- Histone Modifications and Cancer
- (2016) James E. Audia et al. Cold Spring Harbor Perspectives in Biology
- Epigenetic Determinants of Cancer
- (2016) Stephen B. Baylin et al. Cold Spring Harbor Perspectives in Biology
- Daxx inhibits hypoxia-induced lung cancer cell metastasis by suppressing the HIF-1α/HDAC1/Slug axis
- (2016) Ching-Wen Lin et al. Nature Communications
- HDAC10 promotes lung cancer proliferation via AKT phosphorylation
- (2016) Yiwei Yang et al. Oncotarget
- HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases
- (2016) Elizabeth E. Hull et al. Biomed Research International
- Histone acetyltransferases: challenges in targeting bi-substrate enzymes
- (2016) Hannah Wapenaar et al. Clinical Epigenetics
- A phase I trial of panobinostat (LBH589) in patients with metastatic melanoma
- (2016) Nageatte Ibrahim et al. Cancer Medicine
- Outcomes of Adolescent and Adult Patients with Lung Metastatic Osteosarcoma and Comparison of Synchronous and Metachronous Lung Metastatic Groups
- (2016) Ayse Gok Durnali et al. PLoS One
- KAT6B Is a Tumor Suppressor Histone H3 Lysine 23 Acetyltransferase Undergoing Genomic Loss in Small Cell Lung Cancer
- (2015) Laia Simó-Riudalbas et al. CANCER RESEARCH
- Distinctive role of SIRT1 expression on tumor invasion and metastasis in breast cancer by molecular subtype
- (2015) Yul Ri Chung et al. HUMAN PATHOLOGY
- Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- (2015) Catherine Van Poznak et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials
- (2015) LANCET
- HIF targets in bone remodeling and metastatic disease
- (2015) Rachelle W. Johnson et al. PHARMACOLOGY & THERAPEUTICS
- Histone Deacetylases in Bone Development and Skeletal Disorders
- (2015) Elizabeth W. Bradley et al. PHYSIOLOGICAL REVIEWS
- CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models
- (2015) Giovanni Luca Gravina et al. PROSTATE
- ANGPTL2 increases bone metastasis of breast cancer cells through enhancing CXCR4 signaling
- (2015) Tetsuro Masuda et al. Scientific Reports
- Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype
- (2015) Gyu-Beom Jang et al. Scientific Reports
- Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer
- (2014) Rachelle W. Johnson et al. CLINICAL & EXPERIMENTAL METASTASIS
- Inhibition of p300 suppresses growth of breast cancer. Role of p300 subcellular localization
- (2014) María E. Fermento et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Direct measurement of local oxygen concentration in the bone marrow of live animals
- (2014) Joel A. Spencer et al. NATURE
- The Histone Deacetylase Inhibitor, Vorinostat, Represses Hypoxia Inducible Factor 1 Alpha Expression through Translational Inhibition
- (2014) Darren M. Hutt et al. PLoS One
- Writers and Readers of Histone Acetylation: Structure, Mechanism, and Inhibition
- (2014) R. Marmorstein et al. Cold Spring Harbor Perspectives in Biology
- Erasers of Histone Acetylation: The Histone Deacetylase Enzymes
- (2014) E. Seto et al. Cold Spring Harbor Perspectives in Biology
- Effect of the HDAC inhibitor vorinostat on the osteogenic differentiation of mesenchymal stem cells in vitro and bone formation in vivo
- (2013) Song Xu et al. ACTA PHARMACOLOGICA SINICA
- Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer - overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression
- (2013) Berit Maria Müller et al. BMC CANCER
- A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer
- (2013) Dana E. Rathkopf et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Lysine Acetyltransferase GCN5 Potentiates the Growth of Non-small Cell Lung Cancer via Promotion of E2F1, Cyclin D1, and Cyclin E1 Expression
- (2013) Long Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Treatment With a Nonsteroidal Aromatase Inhibitor
- (2013) Denise A. Yardley et al. JOURNAL OF CLINICAL ONCOLOGY
- TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling
- (2013) Paloma Bragado et al. NATURE CELL BIOLOGY
- Efficacy of Histone Deacetylase and Estrogen Receptor Inhibition in Breast Cancer Cells Due to Concerted down Regulation of Akt
- (2013) Scott Thomas et al. PLoS One
- Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathways
- (2013) F Bruzzese et al. Cell Death & Disease
- Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells
- (2013) M R Milone et al. Cell Death & Disease
- SIRT1 Suppresses the Epithelial-to-Mesenchymal Transition in Cancer Metastasis and Organ Fibrosis
- (2013) Petra Simic et al. Cell Reports
- Myeloma as a model for the process of metastasis: implications for therapy
- (2012) I. M. Ghobrial BLOOD
- Inhibition of stromal CXCR4 impairs development of lung metastases
- (2012) Crescenzo D’Alterio et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Overall Survival Improvement in Patients with Lung Cancer and Bone Metastases Treated with Denosumab Versus Zoledronic Acid: Subgroup Analysis from a Randomized Phase 3 Study
- (2012) Giorgio Vittorio Scagliotti et al. Journal of Thoracic Oncology
- Phase II trial of the histone deacetylase inhibitor romidepsin in patients with recurrent/metastatic head and neck cancer
- (2012) Missak Haigentz et al. ORAL ONCOLOGY
- Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer
- (2012) Ryung S. Kim et al. PLoS One
- Potential Role of Estrogen Receptor Beta as a Tumor Suppressor of Epithelial Ovarian Cancer
- (2012) Carine Bossard et al. PLoS One
- Compensatory functions of histone deacetylase 1 (HDAC1) and HDAC2 regulate transcription and apoptosis during mouse oocyte development
- (2012) P. Ma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Canonical Wnt signaling regulates Slug activity and links epithelial-mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repression
- (2012) Z.-Q. Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Deciphering the molecular and biologic processes that mediate histone deacetylase inhibitor-induced thrombocytopenia
- (2011) M. J. Bishton et al. BLOOD
- Suberoylanilide hydroxamic acid (SAHA; vorinostat) causes bone loss by inhibiting immature osteoblasts
- (2011) Meghan E. McGee-Lawrence et al. BONE
- Modulating Microtubule Stability Enhances the Cytotoxic Response of Cancer Cells to Paclitaxel
- (2011) A. A. Ahmed et al. CANCER RESEARCH
- Distinct and redundant functions of histone deacetylases HDAC1 and HDAC2 in proliferation and tumorigenesis
- (2011) Jennifer Jurkin et al. CELL CYCLE
- High expression of p300 in human breast cancer correlates with tumor recurrence and predicts adverse prognosis
- (2011) Xiang-sheng Xiao et al. Chinese Journal of Cancer Research
- The seed and soil hypothesis revisited-The role of tumor-stroma interactions in metastasis to different organs
- (2011) Robert R. Langley et al. INTERNATIONAL JOURNAL OF CANCER
- Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial
- (2011) Matthew R Smith et al. LANCET
- Histone Deacetylase Inhibitors: Emerging Mechanisms of Resistance
- (2011) Robert W. Robey et al. MOLECULAR PHARMACEUTICS
- A Perspective on Cancer Cell Metastasis
- (2011) C. L. Chaffer et al. SCIENCE
- A Central Role for Hypoxic Signaling in Cartilage, Bone, and Hematopoiesis
- (2011) Erinn B. Rankin et al. Current Osteoporosis Reports
- Pan-histone deacetylase inhibitor panobinostat depletes CXCR4 levels and signaling and exerts synergistic antimyeloid activity in combination with CXCR4 antagonists
- (2010) A. Mandawat et al. BLOOD
- In vivo Dynamics and Distinct Functions of Hypoxia in Primary Tumor Growth and Organotropic Metastasis of Breast Cancer
- (2010) X. Lu et al. CANCER RESEARCH
- Adverse effects of valproate on bone: Defining a model to investigate the pathophysiology
- (2010) Susan M. Senn et al. EPILEPSIA
- The Role of HDAC6 in Cancer
- (2010) Grace I. Aldana-Masangkay et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- The Histone Deacetylase Inhibitor, Vorinostat, Reduces Tumor Growth at the Metastatic Bone Site and Associated Osteolysis, but Promotes Normal Bone Loss
- (2010) J. Pratap et al. MOLECULAR CANCER THERAPEUTICS
- Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis
- (2010) D. Xie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862)
- (2009) Deborah Bradley et al. CANCER
- HDACi – Targets beyond chromatin
- (2009) Marc Buchwald et al. CANCER LETTERS
- A Novel Lung Metastasis Signature Links Wnt Signaling with Cancer Cell Self-Renewal and Epithelial-Mesenchymal Transition in Basal-like Breast Cancer
- (2009) Theresa A. DiMeo et al. CANCER RESEARCH
- JNJ-26481585, a Novel "Second-Generation" Oral Histone Deacetylase Inhibitor, Shows Broad-Spectrum Preclinical Antitumoral Activity
- (2009) J. Arts et al. CLINICAL CANCER RESEARCH
- Vorinostat increases carboplatin and paclitaxel activity in non-small cell lung cancer cells
- (2009) Taofeek K. Owonikoko et al. INTERNATIONAL JOURNAL OF CANCER
- Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study
- (2009) Evanthia Galanis et al. JOURNAL OF CLINICAL ONCOLOGY
- The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer
- (2009) M. C. Crisanti et al. MOLECULAR CANCER THERAPEUTICS
- Cancer micrometastases
- (2009) Klaus Pantel et al. Nature Reviews Clinical Oncology
- Hypoxia and TGF-β Drive Breast Cancer Bone Metastases through Parallel Signaling Pathways in Tumor Cells and the Bone Microenvironment
- (2009) Lauren K. Dunn et al. PLoS One
- Genetic dissection of histone deacetylase requirement in tumor cells
- (2009) M. Haberland et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts
- (2008) Robert L. Jilka et al. BONE
- Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy
- (2008) W Weichert et al. BRITISH JOURNAL OF CANCER
- T Cells Potentiate PTH-Induced Cortical Bone Loss through CD40L Signaling
- (2008) Yuhao Gao et al. Cell Metabolism
- Comparisons of Metastases in Different Organs: Biological and Clinical Implications
- (2008) D. Tarin CLINICAL CANCER RESEARCH
- A Phase II Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) in Metastatic Breast Cancer: A California Cancer Consortium Study
- (2008) T. H. Luu et al. CLINICAL CANCER RESEARCH
- A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study
- (2008) Susan C. Modesitt et al. GYNECOLOGIC ONCOLOGY
- ERα negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor
- (2008) Jiang Fan et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Lysine Acetylation: Codified Crosstalk with Other Posttranslational Modifications
- (2008) Xiang-Jiao Yang et al. MOLECULAR CELL
- Direct regulation of TWIST by HIF-1α promotes metastasis
- (2008) Muh-Hwa Yang et al. NATURE CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started